EditorialU.S. Supreme Court Rules 5-4 to overturn Purdue Pharma Oxycotin Sackler Immunity Settlement, Washington Dc, District of Columbia, United States of America - 27 Jun 2024
EditorialA group rains slips of paper designed to look like prescriptions for OxyContin to protest funding by the Sackler family at the Guggenheim Museum in New York, Feb. 9, 2019. (The New York Times)
EditorialKara Trainor, with photos of her 11-year-old son who was born addicted to OxyContin, in New York on March 10, 2022. (Hilary Swift/The New York Times)
EditorialKara Trainor, with photos of her 11-year-old son who was born addicted to OxyContin, in New York on March 10, 2022. (Hilary Swift/The New York Times)
EditorialThe consulting firm McKinsey & Company offered clients “in-depth experience in narcotics,” from poppy fields to pills more powerful than Purdue’s OxyContin. *(Mark Weaver/The New York Times)
EditorialTiffinee Scott of Maryland, who lost her daugher, Tiarra Renne Brown Lewis, to addiction after she was prescribed OxyContin for pain associated with her sickle cell disease. (Hilary Swift/The New York Times)
EditorialProtesters, including organizer Nan Goldin, bottom right, lay down by a reflecting pool into which they tossed prescription bottles at the Sackler Wing of the Metropolitan Museum of Art, which is named for the family who owns the company Purdue Pharma, maker of OxyContin, in New York, March 10, 2018. (George Etheredge/The New York Times)
EditorialThe company headquarters of Purdue Pharma, makers of the highly addictive painkiller OxyContin, in Stamford, Conn., May 23, 2018. (George Etheredge/The New York Times)
EditorialA 13-foot-long sculpture of a bent heroin spoon, placed as part of a protest against the opioid crisis, outside the headquarters of Purdue Pharma, the makers of the painkiller OxyContin, in Stamford, Conn., June 22, 2018. (Gregg Vigliotti/The New York Times)